Clinical trial
A 3-year, Open-label, Multi-center Extension Trial of Telbivudine Therapy for Patients Previously Treated in EFFORT Clinical Trial
NCT01529255 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 3-year, Open-label, Multi-center Extension Trial of Telbivudine Therapy for Patients Previously Treated in EFFORT Clinical Trial
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- December 31, 2015
- Enrollment
- 576 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.